Characteristics of Menopause: What Impact on Risk of CHD?

Statin-eligible patients in minority groups significantly undertreated; metabolically healthy obesity on the rise; menstruation irregularities suggest later CVD risk; and 2 more studies of note.

Your daily dose of clinical news you may have missed.

Women whose menstrual cycle varied in frequency had a significant 24% greater risk of a composite cardiovascular event during a 26-year follow-up, a new study reports.

Your daily dose of clinical news you may have missed.

A new study found the probability of initiating psycholeptics and having a postpartum psychiatric emergency was lower in early and late discontinuer groups vs the continuer group.

Fezolinetant, a nonhormonal selective neurokinin-3 receptor antagonist, significantly reduced frequency and severity of menopause-related VMS in a pivotal phase 3 trial.